Inhibition of Fibrinolysis by Coagulation Factor XIII

por Rijken, Dingeman C., Uitte de Willige, Shirley
Publicado 2017

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays

por Pieters, Marlien, Barnard, Sunelle A., Loots, Du Toit, Rijken, Dingeman C.
Publicado 2017

Clot Structure and Fibrinolysis in Thrombosis and Hemostasis

por Bagoly, Zsuzsa, Ariëns, Robert A. S., Rijken, Dingeman C., Pieters, Marlien, Wolberg, Alisa S.
Publicado 2017

Identification of Fibrin Clot-Bound Plasma Proteins

por Talens, Simone, Leebeek, Frank W. G., Demmers, Jeroen A. A., Rijken, Dingeman C.
Publicado 2012

Plasma Clot Lysis Time and Its Association with Cardiovascular Risk Factors in Black Africans

por de Lange, Zelda, Pieters, Marlien, Jerling, Johann C., Kruger, Annamarie, Rijken, Dingeman C.
Publicado 2012

In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

por de Lange, Zelda, Rijken, Dingeman C., Hoekstra, Tiny, Conradie, Karin R., Jerling, Johann C., Pieters, Marlien
Publicado 2013

Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review

por de Vries, Judith J., Snoek, Charlotte J.M., Rijken, Dingeman C., de Maat, Moniek P.M.
Publicado 2020

On the localization of the cleavage site in human alpha‐2‐antiplasmin, involved in the generation of the non‐plasminogen binding form

por Abdul, Shiraazkhan, Dekkers, Dick H. W., Ariëns, Robert A. S., Leebeek, Frank W. G., Rijken, Dingeman C., Uitte de Willige, Shirley
Publicado 2020

Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin

por Abdul, Shiraazkhan, Peeters, Miet, Brouwers, Els, Malfliet, Joyce J. M. C., Leebeek, Frank W. G., Declerck, Paul J., Rijken, Dingeman C., Uitte de Willige, Shirley
Publicado 2018

Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation

por de Vries, Judith J., Hoppenbrouwers, Tamara, Martinez-Torres, Cristina, Majied, Rezin, Özcan, Behiye, van Hoek, Mandy, Leebeek, Frank W.G., Rijken, Dingeman C., Koenderink, Gijsje H., de Maat, Moniek P.M.
Publicado 2020

Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease

por Uitte de Willige, Shirley, Keane, Fiona M., Bowen, David G., Malfliet, Joyce J. M. C., Zhang, H. Emma, Maneck, Bharvi, McCaughan, Geoffrey W., Leebeek, Frank W. G., Rijken, Dingeman C., Gorrell, Mark D.
Publicado 2017

Rosuvastatin use increases plasma fibrinolytic potential: a randomised clinical trial

por Schol‐Gelok, Suzanne, de Maat, Moniek P. M., Biedermann, Joseph S., van Gelder, Teun, Leebeek, Frank W. G., Lijfering, Willem M., van der Meer, Felix J. M., Rijken, Dingeman C., Versmissen, Jorie, Kruip, Marieke J. H. A.
Publicado 2020

Levels of Fibrinogen Variants Are Altered in Severe COVID-19

por de Vries, Judith J., Visser, Chantal, van Ommen, Maureen, Rokx, Casper, van Nood, Els, van Gorp, Eric C. M., Goeijenbier, Marco, van den Akker, Johannes P. C., Endeman, Henrik, Rijken, Dingeman C., Kruip, Marieke J. H. A., Weggeman, Miranda, Koopman, Jaap, de Maat, Moniek P. M.
Publicado 2023

Altered fibrin network structure and fibrinolysis in intensive care unit patients with COVID‐19, not entirely explaining the increased risk of thrombosis

por de Vries, Judith J., Visser, Chantal, Geers, Lotte, Slotman, Johan A., van Kleef, Nadine D., Maas, Coen, Bax, Hannelore I., Miedema, Jelle R., van Gorp, Eric C.M., Goeijenbier, Marco, van den Akker, Johannes P.C., Endeman, Henrik, Rijken, Dingeman C., Kruip, Marieke J.H.A., de Maat, Moniek P.M.
Publicado 2022